- Congress Shouldn’t Pass the 21st Century Cures Act in a Summer Rush, Health Affairs Blog – with published comments from NPA FDA Task Force members Lisa Plymate, MD, and Elizabeth Wiley, MD, JD, MPH (7/11/2016)
- Patient advocates urge action on clinical trials reporting, Stat News (4/14/2016)
- More than 50 health, religious and labor groups urge Congress to reject TPP trade deal, Washington Post (4/12/2016)
- Top 5 reasons why Doctors Without Borders and more than 50 other organisations don’t like the TPP, Medium (4/12/2016)
- NPA FDA Task Force Member, Dr. Andrew Kolodny, Joins Senators Markey & Manchin Press Conference: Reform FDA to Address Opioid Crisis (2/22/2016)
- Critics see accountability risk if FDA rule changes take hold, Star Tribune (2/14/2016)
- “Thousands of lives lost”? Why calls for faster drug approvals need more scrutiny, Health News Review (1/7/2016)
- “Defining antibiotic effectiveness and resistance: how a private party may soon rule judgments over susceptibility testing?” BMJ (1/6/2016)
- “Critics continue pounding 21st Century Cures Act for threatening patient safety,” Medical Economics (12/30/2015)
- “The last word: Will 21st Century Cures Act harm patient safety?” Medical Economics (12/25/2015)
- “Deregulating the FDA: Back to thalidomide?” The Hill (12/2/2015)
- “Dr. Andrew Kolodny on Combating Drug Abuse,” C-Span (10/25/2015)
- “How fast to “cures” and at what cost? Politico forum tilts toward pharma-friendly messaging,” HealthNewsReview (10/22/2015)
- “Would Washington’s FDA Fix Cure the Patients or the Drug Industry?,” ProPublica (10/20/2015)
- “’21st Century Cures’ Isn’t a Cure for Everything,” Managed Care (9/2015)
- “FDA Panel Recommends Two New Antibiotics – Speakers Debate Agency’s Approach to Drugs for Resistant Infections,” Wall Street Journal (3/31/2014)
- “Health groups fight Republican push to deregulate medical technology,” The Hill, (2/21/2014)
